Preventive effects of etodolac, a selective cyclooxygenase‐2 inhibitor, on cancer development in extensive metaplastic gastritis, a <i>Helicobacter pylori</i> ‐negative precancerous lesion

Kimihiko Yanaoka(Wakayama Medical University), Masao Ichinose(Wakayama Medical University), Hisanobu Deguchi(Wakayama Medical University), Hideyuki Tamai(Wakayama Medical University), Ken‐ichi Inada(Fujita Health University), Mitsuhiro Fujishiro(Bunkyo University), Izumi Inoue(Wakayama Medical University), Chizu Mukoubayashi(Wakayama Medical University), Noriko Yoshimura(The University of Tokyo), Takao Maekita(Wakayama Medical University), Kazuki Ueda(Kindai University), Yasushi Nakamura(Kindai University), Shotaro Enomoto(Wakayama Medical University), Hirotoshi Utsunomiya(Tokai University), Masashi Oka(Wakayama Medical University), Tetsuya Tsukamoto(Memorial Sloan Kettering Cancer Center), Tatsuya Takeshita(Wakayama Medical University), Mikitaka Iguchi(Wakayama Medical University)
International Journal of Cancer
August 26, 2009
Cited by 40


Related Papers